Zhejiang Medicine: Completed repurchase of 1.43% of shares.

Zhejiang Medicine Announcement, on August 11, 2025, the company completed the repurchase, accumulating a total of 13.7232 million shares of the company through the Shanghai Stock Exchange system through centralized bidding, accounting for 1.43% of the company's current total share capital. The highest repurchase price was 16.09 yuan per share, the lowest price was 13.31 yuan per share, the average repurchase price was 14.57 yuan per share, and the total amount of funds used was 200 million Chinese yuan. This repurchase of shares will be used for the subsequent implementation of an employee shareholding plan or equity incentive.